These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 30328784)

  • 21. An improved method for the derivation of high quality iPSCs in the absence of c-Myc.
    Habib O; Habib G; Choi HW; Hong KS; Do JT; Moon SH; Chung HM
    Exp Cell Res; 2013 Dec; 319(20):3190-200. PubMed ID: 24095950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
    Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
    Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentiation of blood T cells: Reprogramming human induced pluripotent stem cells into neuronal cells.
    Tsai PH; Chang YC; Lee YY; Ko YL; Yang YH; Lin CF; Chang YL; Yu WC; Shih YH; Chen MT
    J Chin Med Assoc; 2015 Jun; 78(6):353-9. PubMed ID: 26022695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cocktail of Chemical Compounds and Recombinant Proteins Robustly Promote the Stemness of Adipose-Derived Stem Cells.
    Guo Y; Yu Q; Mathew S; Lian R; Xue Y; Cui Z; Li S; Zhu D; Han Y; Zeng Q; Liu S; Chen J
    Cell Reprogram; 2017 Dec; 19(6):363-371. PubMed ID: 29215942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA Replacing Oncogenic Klf4 and c-Myc for Generating iPS Cells via Cationized Pleurotus eryngii Polysaccharide-based Nanotransfection.
    Deng W; Cao X; Chen J; Zhang Z; Yu Q; Wang Y; Shao G; Zhou J; Gao X; Yu J; Xu X
    ACS Appl Mater Interfaces; 2015 Sep; 7(34):18957-66. PubMed ID: 26269400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of induced pluripotent stem cells from buffalo (Bubalus bubalis) fetal fibroblasts with buffalo defined factors.
    Deng Y; Liu Q; Luo C; Chen S; Li X; Wang C; Liu Z; Lei X; Zhang H; Sun H; Lu F; Jiang J; Shi D
    Stem Cells Dev; 2012 Sep; 21(13):2485-94. PubMed ID: 22420535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of pluripotency in long-term cryopreserved human neonatal fibroblasts in feeder-free condition.
    Csobonyeiova M; Krajciova L; Nicodemou A; Polak S; Danisovic L
    Cell Tissue Bank; 2017 Mar; 18(1):45-52. PubMed ID: 27873029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methods for Isolation and Reprogramming of Various Somatic Cell Sources into iPSCs.
    Neeman-Egozi S; Baskin P; Binah O
    Methods Mol Biol; 2022; 2454():643-655. PubMed ID: 34128204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells.
    Li HY; Chien Y; Chen YJ; Chen SF; Chang YL; Chiang CH; Jeng SY; Chang CM; Wang ML; Chen LK; Hung SI; Huo TI; Lee SD; Chiou SH
    Biomaterials; 2011 Sep; 32(26):5994-6005. PubMed ID: 21658760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Application of Induced Pluripotent Stem Cells in Cardiovascular Medicine.
    Chi HJ; Gao S; Yang XC; Cai J; Zhao WS; Sun H; Geng YJ
    Cardiology; 2015; 131(4):236-44. PubMed ID: 25969168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of Individualized Induced Pluripotent Stem Cells From Fibroblasts of Keloid Lesions in Patients.
    Zhang YX; Liu LP; Li M; Huang JL; Xu H; Chen XD; Zhu WY; Cai YP; Guo NN; Chen ZQ; Zheng YW; Li YM
    Transplant Proc; 2018 Nov; 50(9):2868-2871. PubMed ID: 30401414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histone variants enriched in oocytes enhance reprogramming to induced pluripotent stem cells.
    Shinagawa T; Takagi T; Tsukamoto D; Tomaru C; Huynh LM; Sivaraman P; Kumarevel T; Inoue K; Nakato R; Katou Y; Sado T; Takahashi S; Ogura A; Shirahige K; Ishii S
    Cell Stem Cell; 2014 Feb; 14(2):217-27. PubMed ID: 24506885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induced pluripotent stem cells from goat fibroblasts.
    Song H; Li H; Huang M; Xu D; Gu C; Wang Z; Dong F; Wang F
    Mol Reprod Dev; 2013 Dec; 80(12):1009-17. PubMed ID: 24123501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induced pluripotent stem cells and their implication for regenerative medicine.
    Csobonyeiova M; Polak S; Koller J; Danisovic L
    Cell Tissue Bank; 2015 Jun; 16(2):171-80. PubMed ID: 25037593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induced pluripotent stem cells (iPSCs): the emergence of a new champion in stem cell technology-driven biomedical applications.
    Das AK; Pal R
    J Tissue Eng Regen Med; 2010 Aug; 4(6):413-21. PubMed ID: 20084623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolome Profiling of Partial and Fully Reprogrammed Induced Pluripotent Stem Cells.
    Park SJ; Lee SA; Prasain N; Bae D; Kang H; Ha T; Kim JS; Hong KS; Mantel C; Moon SH; Broxmeyer HE; Lee MR
    Stem Cells Dev; 2017 May; 26(10):734-742. PubMed ID: 28346802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chicken Induced Pluripotent Stem Cells: Establishment and Characterization.
    Fuet A; Pain B
    Methods Mol Biol; 2017; 1650():211-228. PubMed ID: 28809024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human transgene-free amniotic-fluid-derived induced pluripotent stem cells for autologous cell therapy.
    Jiang G; Di Bernardo J; Maiden MM; Villa-Diaz LG; Mabrouk OS; Krebsbach PH; O'Shea KS; Kunisaki SM
    Stem Cells Dev; 2014 Nov; 23(21):2613-25. PubMed ID: 25014361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malignant germ cell-like tumors, expressing Ki-1 antigen (CD30), are revealed during in vivo differentiation of partially reprogrammed human-induced pluripotent stem cells.
    Griscelli F; Féraud O; Oudrhiri N; Gobbo E; Casal I; Chomel JC; Biéche I; Duvillard P; Opolon P; Turhan AG; Bennaceur-Griscelli A
    Am J Pathol; 2012 May; 180(5):2084-96. PubMed ID: 22425713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induced Pluripotent Stem Cells and Induced Pluripotent Cancer Cells in Cancer Disease Modeling.
    Zhu D; Kong CSL; Gingold JA; Zhao R; Lee DF
    Adv Exp Med Biol; 2018; 1119():169-183. PubMed ID: 30069853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.